子宫动脉栓塞术后妇科癌症的短期发生率
结果显示每497例接受UAE的女性中1例在3年内诊断为妇科恶性肿瘤,发生率为1.1/1000人年,且发生率随年龄增长而升高。
要点
- UAE后3年内妇科恶性肿瘤发生率为1.1/1000人年,即每497例中1例。
- 癌症诊断平均在UAE后1.1±0.9年,其中 uterine cancer 占71%。
- UAE时年龄越大,短期恶性肿瘤诊断率越高:45-54岁1/377,55-64岁1/79。
核心结论
- UAE后短期妇科恶性肿瘤发生率低但随年龄增长而升高,数据有助于UAE及其替代方案的风险/获益咨询和共享决策。
主要发现
- 癌症诊断平均在UAE后1.1±0.9年,每497例UAE女性中1例在3年内诊断为妇科恶性肿瘤,发生率为1.1/1000人年。
- UAE时年龄45至54岁女性短期恶性肿瘤诊断率为1/377,55至64岁为1/79。
临床怎么用
- 可为症状性女性及年龄相关风险女性提供UAE前评估和风险/获益咨询,辅助共享决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To characterize the short-term incidence of gynecologic cancer after undergoing uterine artery embolization (UAE). DESIGN: Retrospective cohort study. SETTING: Commercial insurance claims database. PATIENTS: Total of 15 393 United States women aged 18 to 64 years who underwent UAE between 2007 and 2017. INTERVENTIONS: We used the IBM MarketScan (Armonk, NY) claims to identify adult women without previous gynecologic cancer diagnoses undergoing UAE between 2007 and 2017. Database queries identified women with any diagnostic or procedure codes related to gynecologic malignancies occurring in the first 3 years after UAE. A malignancy diagnosis was suggested by recurrent malignancy-related claims not linked exclusively to diagnostic testing (e.g., transvaginal ultrasound) and malignancy codes linked to tissue pathology claims. Incidence of malignancy diagnosis was calculated. Rates of endometrial sampling in the year before UAE were identified. MEASUREMENTS AND MAIN RESULTS: Thirty-one women undergoing UAE had gynecologic cancer diagnoses within 3 years of the procedure (22 of 31, 71% uterine cancers; 7 of 31, 23% ovarian cancers; and 2 of 31, 6% cervical cancers). On average, cancer diagnoses were made 1.1 ± 0.9 years after UAE. One in 497 women undergoing UAE was diagnosed with a gynecologic malignancy within 3 years, with an incidence of 1.1 malignancies per 1000 person-years. Cancer incidence increased with age at the time of UAE: short-term malignancy diagnoses were made in 1 in 377 women aged 45 to 54 years, and 1 in 79 women aged 55 to 64 years. In the year before UAE, 28% (4311 of 15 362) of women without cancer, and 23% (5 of 22) of women diagnosed with uterine cancer had preprocedural endometrial sampling. CONCLUSION: These data can inform risk/benefit counseling and shared decision-making regarding UAE and its alternatives. Short-term malignancies after UAE highlight the importance of preprocedure evaluation in symptomatic women and women with age-related risk.
引用
- Bronico JVR, Matthews BJ, Perkins RB, et al. Incidence of Gynecologic Cancers in Women after Uterine Artery Embolization. J Minim Invasive Gynecol. 2020. PMID: 33115685. doi:10.1016/j.jmig.2020.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。